What about the anti-malarial drug 'Hydroxychloroquine' that was so much in demand and exported by India. Does it really work? and if yes, Are we using it in India for Covid -19 patients?
@ Dilraj there are so many conflicting outcomes of research on hydrochloroquine but you and I know we safely used it for decades to treat malaria then why the turn of events now?
Ette Etuk Thanks for such information, but how does this possible in Nigeria. Whereas WHO has suspended the clinical trials due to health risk. Does this drug mechanism is demographic dependent?
There is no known evidence as regards its efficacy.. however, in Nigeria for instance, I was part of a study which looked at patients of Covid-19 who are being managed using Hydroxychloriquine and azithromycin and we have seen adverse cardiac effects such as Arrhythmia etc.. so rather than being a solution, it is in itself a problem creator..
A recently published systematic review of 12 clinical studies showed that the safety and efficacy of hydroxycloroquine in COVID-19 is not satisfactory, and that the combination of hydroxychloroquine with azithromycin warrants caution. More RCTs are needed with regard to its role; studies published so far have had major limitations to their methodology. In the mean time, with a lot of contradictory evidence, it is best to refrain from using it.
Dear Dilraj Kaur, Hydroxychloroquine has been used as anti-malarial drug from several years. Although, hydroxychloroquine is being studied to prevent and treat COVID‑19, there is no strong scientific evidence to support the use of this anti-malarial drug for preventing or treating this pandemic. Again, FDA does not approve its use to treat COVID-19. Further, due to health risks WHO already suspended the clinical trial of this drug.
Hydroxychloroquine does not improve outcomes in patients with Covid-19. In fact it may increase mortality by causing prolongation of the QT interval and increasing the incidence of ventricular arrhythmias.